Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 18,097 | 14,632 | 57,230 | 15,254 | 80,911 |
| Cost of Goods | N/A | N/A | N/A | N/A | 1,500 |
| Gross Profit | 18,097 | 14,632 | 57,230 | 15,254 | 79,411 |
| Operating Expenses | 78,976 | 70,096 | 50,278 | 44,143 | 41,355 |
| Operating Income | -60,879 | -55,464 | 6,952 | -28,889 | 38,556 |
| Interest Expense | 0 | 922 | 2,092 | 1,529 | 1,822 |
| Other Income | -3,015 | 5,127 | -26,758 | -2,164 | -468 |
| Pre-tax Income | -63,894 | -51,259 | -21,898 | -32,582 | 36,266 |
| Net Income Continuous | -63,894 | -51,259 | -21,898 | -32,582 | 36,266 |
| Net Income | $-63,894 | $-51,259 | $-21,898 | $-32,582 | $36,266 |
| EPS Basic Total Ops | -1.92 | -1.63 | -4.15 | -24.84 | 0.80 |
| EPS Basic Continuous Ops | -1.92 | -1.63 | -2.33 | -13.57 | 15.58 |
| EPS Diluted Total Ops | -1.92 | -1.63 | -4.15 | -24.84 | 0.78 |
| EPS Diluted Continuous Ops | -1.92 | -1.63 | -2.33 | -13.57 | 13.35 |
| EPS Diluted Before Non-Recurring Items | -1.92 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-59,703 | $-54,310 | $8,053 | $-27,461 | $41,931 |